Genenta Science S.p.A (GNTA) Total Current Liabilities (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Total Current Liabilities of $2.5 million for Q4 2025, up 36.88% sequentially from $1.8 million in Q2 2025, and up 9.89% YoY from $2.2 million in Q4 2024.
Genenta Science S.p.A (GNTA) Total Current Liabilities (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Total Current Liabilities for 6 years, with the latest figure at $2.5 million in Q4 2025.
- Quarterly Total Current Liabilities rose 9.89% year-over-year to $2.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.5 million (up 9.89% YoY) and the FY2025 annual result came in at $2.5 million, up 9.89% from the prior year.
- Total Current Liabilities grew to $2.5 million in Q4 2025 per GNTA's latest filing, from $1.8 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.5 million in Q4 2025 and troughed at $1.3 million in Q2 2022.
- A 5-year average of $1.9 million and a median of $1.9 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Current Liabilities tumbled 53.33% in 2021, then surged 71.57% in 2022.
- Over 5 years, Total Current Liabilities stood at $1.3 million in 2021, then soared by 71.57% to $2.2 million in 2022, then retreated by 16.17% to $1.9 million in 2023, then rose by 20.13% to $2.2 million in 2024, then rose by 9.89% to $2.5 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.5 million, $1.8 million, and $2.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Genenta Science S.p.A | 25.03 Mn | -34.07 Mn | - | 2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.47 Mn |
| Jun 30, 2025 | 1.80 Mn |
| Dec 31, 2024 | 2.24 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Dec 31, 2022 | 2.23 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Dec 31, 2021 | 1.30 Mn |
| Dec 31, 2020 | 2.78 Mn |